VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

Japan donated 200 vials of the drug Fomepizole to treat acute kidney disorders in Indonesia. This was conveyed by the Head of the Communication and Public Service Bureau of the Ministry of Health of the Republic of Indonesia (Kemenkes RI) Siti Nadia Tarmizi.

"This drug (Fomepizole) arrived in Indonesia Saturday (29/10/2022) in the morning. And it was distributed as needed to all provincial-level referral hospitals in Indonesia," said Siti Nadia Tarmizi in Jakarta, Saturday (29/10/2022) night.

Siti said the drug was a donation from PT Takeda Indonesia which was immediately distributed to 14 referral hospitals at the provincial level.

A total of 14 national referral hospitals are located in 13 provinces, namely North Sumatra, South Sumatra, DKI Jakarta, and West Java. And DI Yogyakarta, Central Java, East Java, and Bali. Other provinces are South Kalimantan, West Kalimantan, South Sulawesi, Maluku, and Papua.

The hospitals include RSUP H Adam Malik (Medan), RSUP dr Djamil (Padang), RSUP dr Hoesin (Palembang), and RSUP dr Cipto Mangunkusumo (Jakarta). And RSUP dr Hasan Sadikin (Bandung), RSUP dr Sarjito (Yogyakarta), and RSUP dr Kariadi (Semarang).

Next, Dr Soetomo Hospital (Surabaya), Sanglah Hospital Denpasar (Bali), Dr Soedarso Hospital (Pontianak), and Abdul Wahab Sjahranie Hospital (Samarinda). Also Dr Wahidin Sudiro Husodo Hospital (Makassar), Prof R D Kandou Hospital (Manado) Dok II Hospital Jayapura (Jayapura).

Meanwhile, the Indonesian Minister of Health (Menkes) Budi Gunadi Sadikin said the drug grant was implemented in good faith. In the name of humanity for the benefit of Indonesian children's health.

"This antidote will be given free of charge to all patients in Indonesia," said Minister of Health Budi.

Previously, Indonesia also imported 10 vials of similar drugs on October 10 and 18, 2022, from Singapore. In a trial at RSCM Jakarta, 10 patients who received Fomepizole showed improved health.

"Three children no longer need a ventilator and one person has been discharged. It can be concluded that this drug has a positive impact on the treatment of patients with acute kidney disorders," he said. (RRI)